肾细胞癌
医学
帕唑帕尼
肾癌
癌症
骨转移
转移
癌
正电子发射断层摄影术
原发性肿瘤
肾切除术
肾
病理
活检
无容量
肿瘤科
放射科
内科学
舒尼替尼
免疫疗法
作者
Yunus Emre Boru,Osman Sütçüoğlu,Kübra Çalışkan,Pınar Uyar Göçün,Ozan Yazıcı
出处
期刊:PubMed
日期:2022-12-01
卷期号:32 (12): SS200-SS202
被引量:1
标识
DOI:10.29271/jcpsp.2022.supp0.ss200
摘要
Renal cell carcinoma (RCC) is a common type of cancer, and about 25% of patients are diagnosed at an advanced stage. Bone metastasis is common in RCC, but instances of bone metastases without a primary kidney tumour have rarely been reported. Here, we report a case of a 56-year male patient who presented with extensive bone metastases. The biopsy was reported as clear cell RCC and no primary renal tumour was detected by positron emission tomography and magnetic resonance imaging. Pazopanib was initiated and progression was detected in the 6th month of treatment. Nivolumab was initiated as second line therapy. In the literature, primary unrecognised RCC cases are found only as case reports. This case highlights the importance of clinicians' consideration of possible metastatic RCC in a patient with pathologically diagnosed clear cell carcinoma, even if no primary renal tumour is identified. Key Words: Renal cell carcinoma, İmmunohistochemistry, Diagnosis, Kidney, Cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI